XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement, Employee [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

Stock option activity for employees:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding January 1, 2024   2,408,438   $2.50    8.70   $ 
Granted                
Forfeited                
Expired                
Outstanding March 31, 2024   2,408,438   $2.50    8.70   $ 
Vested and expected to vest March 31, 2024   2,141,772   $1.83    6.89   $ 
Exercisable March 31, 2024   2,141,772   $1.83    6.89   $ 
Schedule of Unvested Stock Option Activity

Unvested stock option activity for employees:

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested January 1, 2024   366,666   $2.13    12.44   $ 
Granted                
Expired                
Vested   (100,000)   0.47    6.89     
Unvested March 31, 2024   266,666   $2.75    14.52   $ 
Share-Based Payment Arrangement, Nonemployee [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

Stock option activity for non-employees:

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding January 1, 2024   885,055   $2.02    9.23   $ 
Granted                
Forfeited                
Expired                
Outstanding March 31, 2024   885,055   $2.02    9.23   $ 
Vested and expected to vest March 31, 2024   640,055   $2.27    10.04   $ 
Exercisable March 31, 2024   640,055   $2.27    10.04   $ 
Schedule of Unvested Stock Option Activity

Unvested stock option activity for non-employees:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested January 1, 2024   335,001   $1.83    10.70   $ 
Granted                
Expired                
Vested   (90,000)   0.46    9.47     
Unvested March 31, 2024   245,001   $2.33    11.15   $